METASTATIC HORMONE RECEPTOR POSITIVE BREAST CANCER
Clinical trials for METASTATIC HORMONE RECEPTOR POSITIVE BREAST CANCER explained in plain language.
Never miss a new study
Get alerted when new METASTATIC HORMONE RECEPTOR POSITIVE BREAST CANCER trials appear
Sign up with your email to follow new studies for METASTATIC HORMONE RECEPTOR POSITIVE BREAST CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New combo therapy aims to boost breast cancer treatment
Disease control Recruiting nowThis early-stage trial tests whether adding the drug avasopasem to standard hormone therapy and a CDK 4/6 inhibitor is safe and can better control metastatic HR+ breast cancer. About 35 women whose cancer has worsened on current treatments will participate. The goal is to see if …
Matched conditions: METASTATIC HORMONE RECEPTOR POSITIVE BREAST CANCER
Phase: PHASE1 • Sponsor: The University of Texas Health Science Center at San Antonio • Aim: Disease control
Last updated Jun 22, 2026 12:07 UTC
-
New targeted therapy duo enters human trials for advanced breast cancer
Disease control Recruiting nowThis early-phase study tests two related drugs: one to help see tumors on scans (68Ga-R11228) and another to deliver radiation directly to cancer cells (177Lu-R11228). It is for people with advanced hormone-receptor positive breast cancer that has spread or come back. The main go…
Matched conditions: METASTATIC HORMONE RECEPTOR POSITIVE BREAST CANCER
Phase: PHASE1 • Sponsor: Radionetics Oncology • Aim: Disease control
Last updated Jun 16, 2026 12:51 UTC
-
Radioactive tracer could spot hidden breast cancer tumors
Diagnosis Recruiting nowThis early-phase trial is testing a new radioactive imaging agent called 68Ga-R10602 in 36 people with hormone receptor-positive breast cancer that has come back or spread. The agent is designed to light up tumors on PET/CT scans. The main goals are to check safety and see how we…
Matched conditions: METASTATIC HORMONE RECEPTOR POSITIVE BREAST CANCER
Phase: PHASE1 • Sponsor: Radionetics Oncology • Aim: Diagnosis
Last updated Jun 23, 2026 11:54 UTC
-
Morning or evening pills? new study seeks best time for cancer meds
Symptom relief Recruiting nowThis study looks at whether taking hormone therapy pills in the morning or evening makes a difference for people with metastatic breast or prostate cancer. About 50 participants will be randomly assigned to take their medication either in the morning or at night. The main goal is…
Matched conditions: METASTATIC HORMONE RECEPTOR POSITIVE BREAST CANCER
Phase: PHASE4 • Sponsor: Ottawa Hospital Research Institute • Aim: Symptom relief
Last updated Jun 17, 2026 12:05 UTC